{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:56:17Z","timestamp":1791240977304,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"DOI":"10.1186\/s12871-026-04088-0","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:14:37Z","timestamp":1783689277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical evaluation of the SeptiScore biomarker for the diagnosis of healthcare-associated infections in critically ill trauma patients: a multicenter derivation and validation cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-5741","authenticated-orcid":false,"given":"Marwan","family":"Bouras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Neutre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Douarec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Goronflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bourdiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexiane","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Arbelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Roquilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"1","key":"4088_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-020-00330-3","volume":"15","author":"JMM Van Breugel","year":"2020","unstructured":"Van Breugel JMM, Niemeyer MJS, Houwert RM, Groenwold RHH, Leenen LPH, Van Wessem KJP. Global changes in mortality rates in polytrauma patients admitted to the ICU\u2014a systematic review. World J Emerg Surg. 2020;15(1):55. https:\/\/doi.org\/10.1186\/s13017-020-00330-3.","journal-title":"World J Emerg Surg"},{"key":"4088_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.995044","volume":"9","author":"M Bouras","year":"2022","unstructured":"Bouras M, Asehnoune K, Roquilly A. Immune modulation after traumatic brain injury. Front Med. 2022;9:995044. https:\/\/doi.org\/10.3389\/fmed.2022.995044.","journal-title":"Front Med"},{"issue":"7","key":"4088_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1001\/archsurg.2011.41","volume":"146","author":"LG Glance","year":"2011","unstructured":"Glance LG. Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients. Arch Surg. 2011;146(7):794. https:\/\/doi.org\/10.1001\/archsurg.2011.41.","journal-title":"Arch Surg"},{"issue":"12","key":"4088_CR4","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1001\/jama.2011.360","volume":"305","author":"A Roquilly","year":"2011","unstructured":"Roquilly A, Mahe PJ, Seguin P, et al. Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA. 2011;305(12):1201\u20139. https:\/\/doi.org\/10.1001\/jama.2011.360.","journal-title":"JAMA"},{"issue":"1","key":"4088_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","volume":"7","author":"A Torres","year":"2021","unstructured":"Torres A, Cilloniz C, Niederman MS, et al. Pneumonia Nat Rev Dis Primer. 2021;7(1):25. https:\/\/doi.org\/10.1038\/s41572-021-00259-0.","journal-title":"Pneumonia Nat Rev Dis Primer"},{"issue":"1","key":"4088_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.51445","volume":"6","author":"K Stern","year":"2023","unstructured":"Stern K, Qiu Q, Weykamp M, O\u2019Keefe G, Brakenridge SC. Defining posttraumatic sepsis for population-level research. JAMA Netw Open. 2023;6(1):e2251445. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.51445.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"4088_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41590-018-0064-8","volume":"19","author":"M Huber-Lang","year":"2018","unstructured":"Huber-Lang M, Lambris JD, Ward PA. Innate immune responses to trauma. Nat Immunol. 2018;19(4):327\u201341. https:\/\/doi.org\/10.1038\/s41590-018-0064-8.","journal-title":"Nat Immunol"},{"key":"4088_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1441","author":"A Roquilly","year":"2020","unstructured":"Roquilly A, Chanques G, Lasocki S, et al. Implementation of French recommendations for the prevention and the treatment of hospital-acquired pneumonia: a cluster-randomized trial. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1441.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"4088_CR9","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1007\/s00134-015-4045-1","volume":"41","author":"A Gouel-Ch\u00e9ron","year":"2015","unstructured":"Gouel-Ch\u00e9ron A, Allaouchiche B, Floccard B, Rimmel\u00e9 T, Monneret G. Early daily mHLA-DR monitoring predicts forthcoming sepsis in severe trauma patients. Intensive Care Med. 2015;41(12):2229\u201330. https:\/\/doi.org\/10.1007\/s00134-015-4045-1.","journal-title":"Intensive Care Med"},{"issue":"3","key":"4088_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/SHK.0b013e3182454acf","volume":"37","author":"Y Seok","year":"2012","unstructured":"Seok Y, Choi JR, Kim J, et al. Delta neutrophil index: a promising diagnostic and prognostic marker for sepsis. Shock. 2012;37(3):242\u20136. https:\/\/doi.org\/10.1097\/SHK.0b013e3182454acf.","journal-title":"Shock"},{"issue":"7","key":"4088_CR11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00134-017-4805-1","volume":"43","author":"E Peronnet","year":"2017","unstructured":"Peronnet E, Venet F, Maucort-Boulch D, et al. Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study. Intensive Care Med. 2017;43(7):1013\u201320. https:\/\/doi.org\/10.1007\/s00134-017-4805-1.","journal-title":"Intensive Care Med"},{"issue":"7","key":"4088_CR12","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1164\/rccm.201502-0355OC","volume":"192","author":"BP Scicluna","year":"2015","unstructured":"Scicluna BP, Klein Klouwenberg PMC, van Vught LA, et al. A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission. Am J Respir Crit Care Med. 2015;192(7):826\u201335. https:\/\/doi.org\/10.1164\/rccm.201502-0355OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"4088_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07108-6","author":"M Jeffrey","year":"2023","unstructured":"Jeffrey M, Denny KJ, Lipman J, Conway Morris A. Differentiating infection, colonisation, and sterile inflammation in critical illness: the emerging role of host-response profiling. Intensive Care Med. 2023. https:\/\/doi.org\/10.1007\/s00134-023-07108-6.","journal-title":"Intensive Care Med"},{"key":"4088_CR14","unstructured":"U.S. Food and Drug Administration. Substantial equivalence determination decision summary SeptiCyte RAPID 2021 Available from: https:\/\/www.accessdata.fda. gov\/cdrh_docs\/reviews\/K203748.pdf. https:\/\/www.accessdata.fda"},{"issue":"5","key":"4088_CR15","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3390\/jcm13051194","volume":"13","author":"R Balk","year":"2024","unstructured":"Balk R, Esper AM, Martin GS, et al. Validation of SeptiCyte RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation. J Clin Med. 2024;13(5):1194. https:\/\/doi.org\/10.3390\/jcm13051194.","journal-title":"J Clin Med"},{"key":"4088_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jcrc.2018.10.028","volume":"49","author":"DM Maslove","year":"2019","unstructured":"Maslove DM, Shapira T, Tyryshkin K, Veldhoen RA, Marshall JC, Muscedere J. Validation of diagnostic gene sets to identify critically ill patients with sepsis. J Crit Care. 2019;49:92\u20138. https:\/\/doi.org\/10.1016\/j.jcrc.2018.10.028.","journal-title":"J Crit Care"},{"issue":"7","key":"4088_CR17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1164\/rccm.201712-2472OC","volume":"198","author":"RR Miller","year":"2018","unstructured":"Miller RR, Lopansri BK, Burke JP, et al. Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU. Am J Respir Crit Care Med. 2018;198(7):903\u201313. https:\/\/doi.org\/10.1164\/rccm.201712-2472OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"4088_CR18","doi-asserted-by":"publisher","unstructured":"McHugh L, Seldon TA, Brandon RA, et al. A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts. Ackland GL, ed. PLOS Med. 2015;12(12):e1001916. https:\/\/doi.org\/10.1371\/journal.pmed.1001916","DOI":"10.1371\/journal.pmed.1001916"},{"issue":"4","key":"4088_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/23744235.2023.2294122","volume":"56","author":"AM Peri","year":"2024","unstructured":"Peri AM, Rafiei N, O\u2019Callaghan K, et al. Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: a prospective multicentre observational study. Infect Dis. 2024;56(4):268\u201376. https:\/\/doi.org\/10.1080\/23744235.2023.2294122.","journal-title":"Infect Dis"},{"issue":"1","key":"4088_CR20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/s41598-023-28178-y","volume":"13","author":"MM Montero","year":"2023","unstructured":"Montero MM, Hardy-Werbin M, Gonzalez-Gallardo S, et al. Evaluation of the host immune response assay SeptiCyte RAPID for potential triage of COVID-19 patients. Sci Rep. 2023;13(1):944. https:\/\/doi.org\/10.1038\/s41598-023-28178-y.","journal-title":"Sci Rep"},{"issue":"4","key":"4088_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"4088_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/(sici)1097-0258(20000229)19:4<453::aid-sim350>3.0.co;2-5","volume":"19","author":"DG Altman","year":"2000","unstructured":"Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med. 2000;19(4):453\u201373. https:\/\/doi.org\/10.1002\/(sici)1097-0258(20000229)19:4%3c453::aid-sim350%3e3.0.co;2-5.","journal-title":"Stat Med"},{"issue":"1","key":"4088_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","volume":"13","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons K. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med. 2015;13(1):1. https:\/\/doi.org\/10.1186\/s12916-014-0241-z.","journal-title":"BMC Med"},{"key":"4088_CR24","doi-asserted-by":"publisher","unstructured":"European Centre for Disease Prevention and Control. Surveillance of Healthcare-Associated Infections in Intensive Care Units: HAI Net ICU Protocol, Version 2.2. Publications Office; 2017. Accessed October 21, 2024. https:\/\/data.europa.eu\/doi\/https:\/\/doi.org\/10.2900\/833186","DOI":"10.2900\/833186"},{"issue":"12","key":"4088_CR25","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1007\/s00134-018-5113-0","volume":"44","author":"D Plachouras","year":"2018","unstructured":"Plachouras D, Lepape A, Suetens C. ECDC definitions and methods for the surveillance of healthcare-associated infections in intensive care units. Intensive Care Med. 2018;44(12):2216\u20138. https:\/\/doi.org\/10.1007\/s00134-018-5113-0.","journal-title":"Intensive Care Med"},{"key":"4088_CR26","doi-asserted-by":"publisher","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest Package: Tests in Linear Mixed Effects Models. J Stat Softw. 2017;82(13). https:\/\/doi.org\/10.18637\/jss.v082.i13","DOI":"10.18637\/jss.v082.i13"},{"issue":"3","key":"4088_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/bimj.200710415","volume":"50","author":"MD Ruopp","year":"2008","unstructured":"Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF. Youden index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J Biom Z. 2008;50(3):419\u201330. https:\/\/doi.org\/10.1002\/bimj.200710415.","journal-title":"Biom J Biom Z"},{"key":"4088_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2025.155128","volume":"89","author":"E Novy","year":"2025","unstructured":"Novy E, Cesarini D, Luc A, Simon M, Guerci P. Diagnostic performance of SeptiCyte RAPID in critically ill patients with occlusive acute mesenteric ischemia: a pilot study. J Crit Care. 2025;89:155128. https:\/\/doi.org\/10.1016\/j.jcrc.2025.155128.","journal-title":"J Crit Care"},{"issue":"3","key":"4088_CR29","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s15010-024-02409-4","volume":"53","author":"M Von Der Forst","year":"2025","unstructured":"Von Der Forst M, Back L, Tourelle KM, et al. SeptAsTERS- SeptiCyte\u00ae RAPID as assessment tool for early recognition of sepsis \u2013 a prospective observational study. Infection. 2025;53(3):953\u201365. https:\/\/doi.org\/10.1007\/s15010-024-02409-4.","journal-title":"Infection"},{"key":"4088_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/594645","author":"IA Meynaar","year":"2011","unstructured":"Meynaar IA, Droog W, Batstra M, Vreede R, Herbrink P. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract. 2011. https:\/\/doi.org\/10.1155\/2011\/594645.","journal-title":"Crit Care Res Pract"},{"issue":"6","key":"4088_CR31","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1097\/01.CCM.0000063440.19188.ED","volume":"31","author":"A Luzzani","year":"2003","unstructured":"Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003;31(6):1737\u201341. https:\/\/doi.org\/10.1097\/01.CCM.0000063440.19188.ED.","journal-title":"Crit Care Med"},{"issue":"1","key":"4088_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51414-y","volume":"14","author":"M Li","year":"2024","unstructured":"Li M, Qin Y, Zhang X, et al. A biomarker panel of C-reactive protein, procalcitonin and serum amyloid A is a predictor of sepsis in severe trauma patients. Sci Rep. 2024;14(1):628. https:\/\/doi.org\/10.1038\/s41598-024-51414-y.","journal-title":"Sci Rep"},{"issue":"9","key":"4088_CR33","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s001340000580","volume":"26","author":"E Suprin","year":"2000","unstructured":"Suprin E, Camus C, Gacouin A, et al. Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med. 2000;26(9):1232\u20138. https:\/\/doi.org\/10.1007\/s001340000580.","journal-title":"Intensive Care Med"},{"issue":"1","key":"4088_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1342-1","volume":"20","author":"P Ramirez","year":"2016","unstructured":"Ramirez P, Lopez-Ferraz C, Gordon M, et al. From starting mechanical ventilation to ventilator-associated pneumonia, choosing the right moment to start antibiotic treatment. Crit Care. 2016;20(1):169. https:\/\/doi.org\/10.1186\/s13054-016-1342-1.","journal-title":"Crit Care"},{"issue":"9","key":"4088_CR35","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00134-022-06769-z","volume":"48","author":"RA Lukaszewski","year":"2022","unstructured":"Lukaszewski RA, Jones HE, Gersuk VH, et al. Presymptomatic diagnosis of postoperative infection and sepsis using gene expression signatures. Intensive Care Med. 2022;48(9):1133\u201343. https:\/\/doi.org\/10.1007\/s00134-022-06769-z.","journal-title":"Intensive Care Med"},{"key":"4088_CR36","doi-asserted-by":"publisher","unstructured":"Tsitsiklis A, Zha B, Byrne A, et al. Impaired Immune Signaling and Changes in the Lung Microbiome Precede Secondary Bacterial Pneumonia in COVID-19. In Review; 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-380803\/v1","DOI":"10.21203\/rs.3.rs-380803\/v1"},{"issue":"3","key":"4088_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/CCM.0000000000002735","volume":"46","author":"ME Koster-Brouwer","year":"2018","unstructured":"Koster-Brouwer ME, Verboom DM, Scicluna BP, et al. Validation of a novel molecular host response assay to diagnose infection in hospitalized patients admitted to the ICU with acute respiratory failure. Crit Care Med. 2018;46(3):368\u201374. https:\/\/doi.org\/10.1097\/CCM.0000000000002735.","journal-title":"Crit Care Med"},{"key":"4088_CR38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.26458","author":"P Dark","year":"2024","unstructured":"Dark P, Hossain A, McAuley DF, et al. Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-Sepsis randomized clinical trial. JAMA. 2024. https:\/\/doi.org\/10.1001\/jama.2024.26458.","journal-title":"JAMA"},{"issue":"9713","key":"4088_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375(9713):463\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(09)61879-1.","journal-title":"Lancet"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-026-04088-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-04088-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-026-04088-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:35:23Z","timestamp":1791239723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12871-026-04088-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4088"],"URL":"https:\/\/doi.org\/10.1186\/s12871-026-04088-0","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the Institutional Review Board of Nantes university hospital (Groupe Nantais d'\u00c9thique dans le Domaine de la Sant\u00e9\n                      ,\n                      GNEDS; approval numbers GNEDS 23\u201389-07\u2013072 and 25\u201343-04\u2013181). All participants received written information about the study and the use of their personal medical data. Informed consent to participate was obtained through a written non-opposition procedure, and all enrolled patients agreed to the use of their data. The study was conducted in accordance with the Declaration of Helsinki and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"595"}}